230 results on '"Garcia, Ruel T"'
Search Results
2. Mutations in HBV DNA Polymerase Associated With Nucleos(t)ide Resistance Are Rare in Treatment-naive Patients
3. Safety and efficacy of entecavir in adefovir-experienced patients
4. Less-Established Risk Factors Are Common in Asian Americans with Hepatitis C Virus: A Case–Controlled Study
5. Undertreatment of Asian Chronic Hepatitis B Patients on the Basis of Standard Guidelines: A Community-Based Study
6. Medication Nonadherence with Long-Term Management of Patients with Hepatitis B e antigen-Negative Chronic Hepatitis B
7. Management of Common Bile Duct Stones in Cirrhotic Patients with Coagulopathy: A Comparison of Supra-Papillary Puncture and Standard Cannulation Technique
8. Significant Prevalence of Histologic Disease in Patients With Chronic Hepatitis B and Mildly Elevated Serum Alanine Aminotransferase Levels
9. Risk factors, genotype 6 prevalence, and clinical characteristics of chronic hepatitis C in Southeast Asian Americans
10. Adherence to Screening for Hepatocellular Carcinoma Among Patients with Cirrhosis or Chronic Hepatitis B in a Community Setting
11. Prevalence of hepatitis B virus genotype B in Vietnamese patients with chronic hepatitis B
12. Prevalence of Colorectal Neoplasms in Asian Americans
13. Low incidence of hepatitis B e antigen seroconversion in patients treated with oral nucleos(t)ides in routine practice
14. Ethnic differences in viral dominance patterns in patients with hepatitis B virus and hepatitis C virus dual infection
15. Randomized Controlled Trial of Pegylated Interferon-Alfa 2a and Ribavirin in Treatment-Naive Chronic Hepatitis C Genotype 6
16. Histological Disease in Asian-Americans With Chronic Hepatitis B, High Hepatitis B Virus DNA, and Normal Alanine Aminotransferase Levels
17. Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil#
18. Low Proportion of Barrettʼs Esophagus in Asian Americans
19. Role of ethnicity in risk for hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis
20. Unsedated ultrathin EGD is well accepted when compared with conventional sedated EGD: a multicenter randomized trial
21. Racial differences in effectiveness of α-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis
22. Safety and efficacy of entecavir in adefovir-experienced patients
23. High Proportion of Hepatitis C Virus in Community Asian American Patients With Non–Liver-related Complaints
24. High Frequency of Recurrent Viremia After Hepatitis B e Antigen Seroconversion and Consolidation Therapy
25. Mo1893 Evaluation of Treatment-Eligibility for Antiviral Therapy During Follow-up in Chronic Hepatitis B Patients Initially Ineligible for Treatment
26. Sa1043 Outcomes of Oral Antiviral Treatment for Chronic Hepatitis B (CHB) in Routine Clinical Practice
27. Sa1003 High Prevalence of Hepatitis C Virus in Ethnically Diverse Community Patients With Non-Liver Related Gastrointestinal Complaints
28. Sa1087 Less Established Risk Factors are Common in Asian Americans With Hepatitis C Virus: A Case-Control Study
29. Su2044 Incidence of Hepatocellular Carcinoma (HCC) in Non-Cirrhotic and Cirrhotic Patients With Chronic Hepatitis B (CHB): Results of a Multicenter Cohort Study
30. Mo1896 Chronic Hepatitis B (CHB) Treatment Eligibility and Actual Treatment Rates at Community Gastroenterology Clinics and Primary Care Clinics
31. High Rate of Complete Viral Suppression With Combination Therapy in Patients With Chronic Hepatitis B and Prior Treatment Failure
32. Annual Incidence for Hepatocellular Carcinoma (HCC) in Non-Cirrhotic Patients With Chronic Hepatitis B (CHB) and Cirrhotic Patients of All Etiologies
33. Rapid Complete Viral Suppression (CVS) With Entecavir (ETV) in Adefovir (ADV)-Experienced Patients: Interim Report for a Multicenter Study
34. Treatment of Chronic Hepatitis B Patients According to Current Guidelines: A Community-Based Study
35. Long-Term Treatment Response to Entecavir and Adefovir in Treatment-NaïVE Chronic Hepatitis B E Antigen-Negative Patients in a Community Setting
36. High Rate of Recurrent Hepatitis B Viremia Following Treatment-Induced Hepatitis B E Antigen (HBeAg) Seroconversion
37. Proportion of Patients Who Were Previously Ineligible for Anti-HBV Therapy Who Became Eligible After 12 Months of Follow-up: Application of U.S. Panel and AASLD Guidelines
38. Incidence and Predictors of Hepatitis B E Antigen (HBeAg) Seroconversion in Chronic Hepatitis B (CHB) Patients Treated With Anti-HBV Therapy in Routine Clinical Practice
39. Hepatitis B Virus (HBV) Reverse Transcriptase Mutation Prevalence Was Low in Treatment-NaïVE Patients With Chronic Hepatitis B (CHB) Using Inno-Lipa HBV DR3 in a Prospective Multicenter Study
40. HBV Precore C1858T Mutation Does Not Share Similar Clinical or Virologic Characteristics With Other Precore Mutants
41. Similar Treatment Response to Peginterferon and Ribavirin in Asian and Caucasian Patients With Chronic Hepatitis C
42. 314 Randomized Controlled Trial of Pegylated Interferon-Alpha 2a and Ribavirin in Patients With Treatment-NaïVE Chronic Hepatitis C Genotype 6
43. 80 Hepatocellular Carcinoma Incidence in a Cohort of 981 U.S. Patients With Chronic Hepatitis B Without Cirrhosis and Patients With Cirrhosis of All Etiologies
44. M1892 Hepatitis B-E Antigen Positive (HBeAg+) Chronic Hepatitis B (CHB) Patients With Precore (PC) and Basic Core Promoter (BCP) Mutations
45. T1967 Asian Ethnicity is a Significant Predictor for Viral Dominance by HBV in HBV/HCV Co-Infected Patients: A Multicenter, Matched Case-Control Study
46. 636 High Rate of Complete Viral Suppression With Combination Therapy With Tenofovir Using Entecavir or Lamivudine/Emtricitabine in Patients With Chronic Hepatitis B and Prior Monotherapy Failure
47. 634 Treatment Efficacy of Entecavir (ETV) Therapy in Patients Previously Treated With Adefovir (ADV): Interim Report for a Multicenter Study
48. M1903 Long-Term Outcome of Treatment-NaïVE Chronic Hepatitis B (CHB) E Antigen-Negative Treated With Entecavir 0.5 Mg (ETV) or Adefovir 10 Mg (ADV) in a Real-Life Community Setting
49. M1893 Hepatitis B Virus Reverse Transcriptase Mutations Were Not Detected in Treatment-NaïVE Patients With Chronic Hepatitis B Using Inno Lipa HBV DR3: A Prospective Multicenter Study
50. EUS-guided FNA for GI stromal tumors: caveat lector
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.